You Searched For "regeneron stock" and got 20 results
Sort By:
1 min read
Regeneron jumps 10% as Trump gets the drugmaker's antibody treatment
A team of SVB Leerink analysts said Regeneron's treatment could receive emergency use authorization…
Emily Graffeo
2 mins read
27 biotech execs who've sold the most stock
These are Business Insider's biggest healthcare stories for October 29.
Lydia Ramsey Pflanzer
1 min read
27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron, Moderna, Vir, and more.
A Business Insider analysis found 27 biotech insiders who had cashed in more than $10 million in st…
Andrew Dunn
1 min read
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
7 mins read
10 surprises that could rock biotech stocks in 2020, from a Regeneron acquisition, to big sales for key drugs on the cusp of launching
One approach that has caught attention is the link between responses to treatments and the microbio…
Lydia Ramsey
1 min read
Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill
The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…
Matthew Fox
1 min read
Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first human trials
Intellia partnered with Regeneron in 2016 to advance the CRISPR technology for in vivo therapeutic …
Matthew Fox
3 mins read
US stocks rise as investors weigh latest comments on stimulus progress
Major indexes pared early gains after House Speaker Nancy Pelosi said she would only back smaller r…
Ben Winck
3 mins read
US stocks climb on revived stimulus optimism and lower jobless claims
New US jobless claims for the week that ended on Saturday fell slightly, to 840,000, but were still…
Ben Winck
2 mins read
Dow climbs 260 points amid optimism that Trump will soon be discharged from the hospital
Investors have also recently been encouraged by signs that another round of fiscal stimulus will so…
Matthew Fox
2 mins read
Dow surges 466 points with Trump set to leave the hospital
President Trump's planned hospital departure and continued fiscal stimulus negotiations helped boos…
Matthew Fox
1 min read
US companies sold stock at the fastest rate ever in May as markets rallied
Public US companies in 2020 have sold more than $120 billion of new shares, the highest since 2015,…
Carmen Reinicke
2 mins read
A biotech investor reportedly made $255 million in just 4 weeks on Novavax's 120% surge
Shares of the pharmaceutical company Novavax have surged nearly 2,300% this year. The company is wo…
Carmen Reinicke
2 mins read
US stocks climb on economic reopening hope, oil-price rebound
Optimism around the containment of coronavirus drowned out reports showing the trade deficit swelli…
Ben Winck
8 mins read
As the pandemic raged, at least 75 lawmakers bought and sold stock in companies that make COVID-19 vaccines, treatments, and tests
At least 75 federal lawmakers held shares of the COVID-19 vaccine makers Moderna, Johnson & Johnson…
Camila DeChalus,Kimberly Leon…
2 mins read
Stocks slide as China cancels US farmer visit
Netflix's stock price tumbled as much as 7% after a Bernstein analyst said the company's shares cou…
Daniel Strauss
3 mins read
Tech stocks slide as Google faces renewed antitrust pressure
WeWork, which is expected to conduct one of the most highly-anticipated IPOs of the year, could cut…
Daniel Strauss
2 mins read
Goldman Sachs has identified the stocks poised to crush the market thanks to tax cuts
Goldman's screen for companies that meet this requirement brings it to a 50-stock group it calls it…
Joe Ciolli
1 min read
The Stock Market Win Streak Is In Day 6
Another big winner is Netflix, which is up 6% today. On Monday afternoon, the company announced Q1 …
Sam Ro
2 mins read
Drugmaker Sanofi Fired Its CEO And The Stock Is Tanking
In the letter, Viehbacher wrote that "it has come to my attention, first through rumor, that the ch…